Allergy Research Group Launches CurcuWIN® 500

June 25, 2018

For Immediate Release

Allergy Research Group is pleased to announce CurcuWIN® 500, providing turmeric (Curcuma longa) root extract with significantly higher absorption compared to other curcumin ingredients.

In the first curcumin study of its kind to compare commercial curcumin products, CurcuWIN® showed increased relative absorption of total curcuminoids 46-times over standard curcumin.* This well-controlled human clinical trial also demonstrated that CurcuWIN® has longer-lasting action with higher serum concentrations after 12 hours.* 

CurcuWIN® curcumin uses a molecular dispersion process (Ultrasol technology) which converts oil soluble nutrients into water-dispersible ingredients to enhance bioavailability and retention.* CurcuWIN® 500 is concentrated to minimum 20% curcuminoids, 500 mg per capsule.

Key Features

  • Curcumin supports the overall body, including the musculoskeletal system, GI tract, liver and gallbladder, brain, lungs, skin, and urinary system*
  • CurcuWIN® supplies curcuminoids in the same profile as found naturally in turmeric
  • UltraSOL Delivery System increases relative absorption of total curcuminoids over standard curcumin by 46-times and has higher serum concentrations after 12 hours*
  • Better absorption, protection, and retention provides benefits at a lower dose than other forms of curcumin*

To learn more about CurcuWIN® 500, visit the ARG web site, or call our customer service team at 1-800-545-9960, extension 2.

CONTACT:
Allergy Research Group, LLC.
Dan Mallar, National Sales Director
dan.mallar@allergyresearchgroup.com

CurcuWIN® is a registered trademark of OmniActive Health Technologies, Ltd.

 

*This statement has not been evaluated by the U.S. Food and Drug administration. The product is not intended to diagnose, treat, cure, or prevent any disease.

One thought on “Allergy Research Group Launches CurcuWIN® 500

Comments are closed.